Global Vascular Closure Equipment Market Size By Type (Active Approximators, Passive Approximators), By Application (Diagnostic Intervention, Therapeutic Intervention), By Region, And Segment Forecast...

lobal Vascular Closure Equipment Market Report Description

The Global Vascular Closure Equipment Market was valued at USD 1.3 billion in 2023 and is projected to surpass USD 2.4 billion by 2031, registering a CAGR of 7.8% during the forecast period of 2023–2031.

The market growth is driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and technological advancements in vascular closure devices. These devices are widely used to achieve hemostasis after catheterization procedures, significantly reducing patient recovery time and hospital stays.

The ongoing shift toward same-day discharge protocols, combined with the growing geriatric population, is further boosting the adoption of vascular closure equipment. Additionally, rising investments in healthcare infrastructure across emerging markets are creating substantial growth opportunities.

Drivers

Increasing Cardiovascular Procedures

The global burden of cardiovascular diseases has led to a higher number of catheterization and angiography procedures. This directly drives the need for effective vascular closure devices to ensure patient safety and quick recovery.

Technological Advancements

Next-generation vascular closure devices with enhanced safety profiles, bioabsorbable materials, and improved deployment mechanisms are gaining rapid adoption.

Minimally Invasive Trends

The preference for minimally invasive cardiovascular interventions, which require quick hemostasis, has significantly increased the demand for vascular closure devices.

Restraints

High Device Cost and Limited Reimbursement

The relatively high cost of advanced closure devices, combined with limited reimbursement policies in some regions, can hinder widespread adoption.

Risk of Complications

In rare cases, improper use of vascular closure equipment can lead to complications such as infection or arterial damage, impacting clinician confidence.

Opportunity

Emerging Markets Expansion

Rapid urbanization, improved healthcare access, and increasing cardiovascular disease prevalence in Asia-Pacific and Latin America present lucrative opportunities.

Adoption of Bioabsorbable Closure Devices

Growing demand for bioabsorbable and patient-friendly closure devices is opening new avenues for innovation and market growth.

Market by System Type Insights

Based on product type, Passive Vascular Closure Devices held the largest market share in 2023 due to their wide availability and lower cost. However, the Active Vascular Closure Devices segment is expected to witness the highest growth during the forecast period, driven by faster hemostasis, reduced ambulation time, and improved patient outcomes.

Market by End-use Insights

The Hospital segment accounted for the largest revenue share in 2023, supported by the high volume of catheterization procedures performed in large healthcare facilities. Ambulatory surgical centers are projected to record significant growth due to the rising trend of same-day discharge for minimally invasive procedures.

Market by Regional Insights

North America dominated the global vascular closure equipment market in 2023, fueled by advanced healthcare infrastructure, high procedural volumes, and strong presence of leading players.

Europe maintains a significant share, driven by the increasing adoption of advanced closure technologies.

Asia-Pacific is expected to witness the fastest growth during 2023–2031, owing to rising cardiovascular disease burden, improving healthcare facilities, and growing awareness about advanced closure solutions.

Competitive Scenario

Key players operating in the Global Vascular Closure Equipment Market include Abbott Laboratories, Terumo Corporation, Cardinal Health, Teleflex Incorporated, Merit Medical Systems, Morris Innovative, Vasorum Ltd., Essential Medical, and Cardinal Health.

These companies focus on strategic collaborations, product launches, and acquisitions to strengthen their market position. For instance:

In 2024, Abbott launched a next-generation bioabsorbable vascular closure device targeting rapid hemostasis.

In 2023, Terumo Corporation expanded its portfolio with a new active closure device designed for same-day discharge protocols.

In 2023, Merit Medical acquired a leading European closure device manufacturer to enhance its product reach in the region.

Scope of Work – Global Vascular Closure Equipment Market

Key Market Developments

2024: Abbott introduced a fully bioabsorbable vascular closure device aimed at enhancing patient comfort and safety.

2023: Terumo Corporation launched an active closure device with enhanced deployment accuracy for complex interventions.

2023: Teleflex entered a strategic collaboration with a major hospital network to accelerate the adoption of its closure devices in North America.

FAQs

What is the current market size of the Global Vascular Closure Equipment Market?

The market was valued at USD 1.3 billion in 2023.

What is the major growth driver of the Global Vascular Closure Equipment Market?

Rising cardiovascular procedures and technological advancements in closure devices are the primary growth drivers.

Which is the largest region during the forecast period in the Global Vascular Closure Equipment Market?

North America is expected to remain the largest regional market due to high procedural volumes and advanced healthcare infrastructure.

Which segment accounted for the largest market share in the Global Vascular Closure Equipment Market?

Passive Vascular Closure Devices held the largest share in 2023, while active devices are projected to grow faster.

Who are the key market players in the Global Vascular Closure Equipment Market?

Major players include Abbott, Terumo Corporation, Teleflex Incorporated, Cardinal Health, and Merit Medical Systems.

Would you like me to also create a visually appealing infographic summary for this report? Or should I generate a PDF version of this structured report for easy sharing?